Conference

World CB & CDx US 2018

Meet with Q2 Solutions (booth #7) and discover how we can partner with you for successful Companion Diagnostics

Boston, Massachusetts | October 04, 2018 - October 05, 2018 | 08:00 - 17:00 Add to Calendar
Register to receive presentation schedule a meeting

About This Event

Q2 Solutions’ end-to-end laboratory services can help you simplify and align your co-development strategies to speed development and increase the probability of regulatory and commercial success.

We work with you to determine predictive biomarker solutions, having helped develop diagnostics for many of the biomarkers used today, including PD-1/PD-L1, BCR-ABl, ALK, BRAF, EGFR, KRAS and HER2.

Join Q2 Solutions’ CSO, Patrice Hugo, who will be part of the “Closing Gaps in Care with Population Health Analytics and Community-Based Implementation Programs” panel discussion, on October 4th, at 1.30pm.

Schedule a meeting with our team at this year’s World CB and CDx Boston.

We look forward to meeting you in Boston.

Related Services:

Register for Event

Speakers

Patrice Hugo, Ph.D.
Immunology; Chief Scientific Officer

Dr. Hugo brings more than 25 years of senior scientific leadership experience with extensive management expertise in laboratory operations applied to diagnostics, therapeutic targets and clinical trials. Most recently, Dr. Hugo was Associate Vice President and Chief Scientist at LabCorp/Covance. He has held several other senior leadership positions at companies including Clearstone Central Laboratories, Caprion and PROCREA BioSciences. A noted industry expert, Dr. Hugo has more than 75 scientific publications in internationally renowned journals. He also is active in a number of industry organizations, including his role on the Board of Directors for the non-for-profit Personalized Medicine Partnership for Cancer in Quebec, Warnex, offering analytical and bioanalytical services and his role as a Steering Committee Member for the Biomarker Factory.

Dr. Hugo obtained his Ph.D. at McGill University and completed five years of post- doctoral fellowship at the Walter Elisa Hall Institute in Australia, and Howard Hughes Medical Institute in Denver, Colorado.

Updated as of September 2018.

Companion Diagnostic Expertise

Learn how we can ensure success in your next companion diagnostic development program

Companion Diagnostic Development: Current trends and recommendations

Read More